Your browser doesn't support javascript.
loading
Pharmacogenetics of sodium-glucose co-transporter-2 inhibitors: Validation of a sex-agnostic pharmacodynamic biomarker.
Taylor, Simeon I; Cherng, Hua-Ren; Shahidzadeh Yazdi, Zhinous; Montasser, May E; Whitlatch, Hilary B; Mitchell, Braxton D; Shuldiner, Alan R; Streeten, Elizabeth A; Beitelshees, Amber L.
Affiliation
  • Taylor SI; Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Cherng HR; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Shahidzadeh Yazdi Z; Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Montasser ME; Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Whitlatch HB; Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Mitchell BD; Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Shuldiner AR; Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Streeten EA; Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Beitelshees AL; Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Diabetes Obes Metab ; 25(12): 3512-3520, 2023 12.
Article de En | MEDLINE | ID: mdl-37608471
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Symporteurs / Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 / Glycosurie Limites: Female / Humans / Male Langue: En Journal: Diabetes Obes Metab Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Symporteurs / Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 / Glycosurie Limites: Female / Humans / Male Langue: En Journal: Diabetes Obes Metab Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique